Barclays PLC Johnson & Johnson Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$145.48 - $167.38 $10.4 Million - $12 Million	-71,600 Reduced 58.88%	50,000 $8.1 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $11.3 Million - $12.3 Million	78,200 Added 180.18%	121,600 $17.8 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $7.7 Million - $8.07 Million	-49,600 Reduced 53.33%	43,400 $6.87 Million
Q4 2023 Feb 15, 2024	BUY	$145.6 - $158.88 $13.5 Million - $14.8 Million	93,000 New	93,000 $14.6 Million
Q1 2023 May 04, 2023	SELL	$151.05 - $180.26 $4.98 Million - $5.95 Million	-33,000 Reduced 37.84%	54,200 $8.4 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $12.3 Million - $13.8 Million	76,600 Added 722.64%	87,200 $15.4 Million
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $1.71 Million - $1.9 Million	10,600 New	10,600 $1.73 Million
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $62.3 Million - $69.2 Million	-385,700 Reduced 96.26%	15,000 $2.42 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $34.2 Million - $39.2 Million	249,200 Added 164.49%	400,700 $63.1 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $1.31 Million - $1.43 Million	-9,300 Reduced 5.78%	151,500 $22.6 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $5.94 Million - $7.17 Million	46,100 Added 40.19%	160,800 $22.6 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $13.1 Million - $18.2 Million	-118,100 Reduced 50.73%	114,700 $15 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $8.56 Million - $9.83 Million	67,100 Added 40.49%	232,800 $34 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $12.9 Million - $14.5 Million	-101,900 Reduced 38.08%	165,700 $21.4 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $5.82 Million - $6.4 Million	-44,400 Reduced 14.23%	267,600 $37.3 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $16.9 Million - $18.8 Million	-134,800 Reduced 30.17%	312,000 $43.6 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $8.91 Million - $10.7 Million	72,500 Added 19.37%	446,800 $57.7 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $12.3 Million - $14.5 Million	101,500 Added 37.21%	374,300 $51.7 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $10.9 Million - $12 Million	90,900 Added 49.97%	272,800 $33.1 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $20.8 Million - $24.6 Million	-166,100 Reduced 47.73%	181,900 $23.3 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $19.7 Million - $21.6 Million	150,100 Added 75.85%	348,000 $48.6 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $25.6 Million - $26.8 Million	197,900	197,900 $25.7 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account